Aclaris Therapeutics Inc. (ACRS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
2.50
0.02 (0.81%)
At close: Jan 14, 2025, 3:59 PM
2.57
3.01%
Pre-market Jan 15, 2025, 08:46 AM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 39.88M | 45.28M | 27.35M | 54.13M | 35.94M | 57.02M | 208.85M | 30.17M | 9.85M | 10.76M | 9.59M |
Short-Term Investments | 79.23M | 172.29M | 164.06M | 32.07M | 39.08M | 110.95M | 173.66M | 107.05M | 75.02M | 5.37M | 3.74M |
Long-Term Investments | 62.77M | 12.24M | 34.24M | n/a | n/a | n/a | 15.00M | 36.91M | 7.17M | 518.00K | 802.00K |
Other Long-Term Assets | 3.89M | -630.00K | 3.55M | 4.51M | 4.83M | 332.00K | 279.00K | -35.44M | -5.49M | 10.00K | n/a |
Receivables | 298.00K | 484.00K | 623.00K | 772.00K | 704.00K | 563.00K | 481.00K | n/a | n/a | n/a | n/a |
Inventory | n/a | -12.24M | -34.24M | n/a | 4.97M | 791.00K | -6.36M | n/a | n/a | n/a | n/a |
Other Current Assets | 9.45M | 13.49M | 25.99M | 5.18M | 9.83M | 10.17M | 9.77M | 2.67M | 3.10M | 204.00K | 62.00K |
Total Current Assets | 128.86M | 231.55M | 205.03M | 57.49M | 83.80M | 179.50M | 208.85M | 174.13M | 92.04M | 16.33M | 13.39M |
Property-Plant & Equipment | 1.62M | 1.10M | 1.33M | 1.65M | 2.47M | 4.28M | 2.16M | 481.00K | 360.00K | 515.00K | 19.00K |
Goodwill & Intangibles | 269.00K | 6.97M | 7.05M | 7.12M | 7.20M | 91.45M | 25.85M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 68.55M | 23.05M | 46.18M | 13.29M | 14.49M | 96.07M | 34.66M | 1.95M | 2.04M | 1.04M | 821.00K |
Total Assets | 197.41M | 254.60M | 251.21M | 70.78M | 98.30M | 275.57M | 243.51M | 176.09M | 94.08M | 17.38M | 14.21M |
Account Payables | 8.88M | 10.35M | 9.98M | 5.25M | 9.92M | 11.68M | 7.82M | 2.85M | 810.00K | 1.26M | 353.00K |
Deferred Revenue | n/a | n/a | 10.05M | 5.91M | 7.72M | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 426.00K | 1.37M | 1.39M | 1.21M | 1.27M | 142.00K | 142.00K | n/a | n/a | n/a | n/a |
Other Current Liabilities | 21.65M | 10.22M | 11.56M | 8.41M | 11.24M | 15.53M | 4.80M | 3.38M | 745.00K | 188.00K | 14.00K |
Total Current Liabilities | 30.95M | 21.94M | 22.93M | 14.87M | 22.43M | 27.34M | 12.76M | 6.22M | 1.55M | 1.45M | 367.00K |
Long-Term Debt | n/a | n/a | n/a | 10.65M | n/a | 29.91M | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 9.27M | 34.67M | 30.57M | 7.24M | 5.40M | 2.64M | 4.94M | 372.00K | n/a | 36.68M | 23.00M |
Total Long-Term Liabilities | 9.27M | 35.04M | 30.94M | 18.26M | 5.95M | 33.10M | 5.49M | 372.00K | n/a | 36.68M | 23.00M |
Total Liabilities | 40.23M | 56.98M | 53.87M | 33.13M | 28.39M | 60.44M | 18.25M | 6.59M | 1.55M | 38.13M | 23.37M |
Total Debt | 426.00K | 684.00K | 693.00K | 11.26M | 637.00K | 30.52M | 142.00K | n/a | n/a | n/a | n/a |
Common Stock | 1K | 1K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -770.80M | -682.32M | -595.41M | -504.54M | -453.53M | -292.17M | -159.44M | -90.91M | -42.83M | -20.75M | -9.17M |
Comprehensive Income | -106.00K | -897.00K | -224.00K | -94.00K | -66.00K | -69.00K | -246.00K | -269.00K | -149.00K | -6.00K | 3.00K |
Shareholders Equity | 157.18M | 197.62M | 197.34M | 37.65M | 69.91M | 215.12M | 225.26M | 169.49M | 92.52M | -20.75M | -9.16M |
Total Investments | 142.00M | 184.54M | 198.31M | 32.07M | 39.08M | 110.95M | 188.65M | 143.96M | 82.19M | 5.89M | 4.54M |